336 related articles for article (PubMed ID: 16113443)
1. Post-transcriptional and nongenomic effects of glucocorticoids.
Stellato C
Proc Am Thorac Soc; 2004; 1(3):255-63. PubMed ID: 16113443
[TBL] [Abstract][Full Text] [Related]
2. Genomic and nongenomic effects of glucocorticoids.
Stahn C; Buttgereit F
Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
[TBL] [Abstract][Full Text] [Related]
3. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index.
Schäcke H; Rehwinkel H; Asadullah K; Cato AC
Exp Dermatol; 2006 Aug; 15(8):565-73. PubMed ID: 16842594
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of glucocorticoid receptor signaling.
Labeur M; Holsboer F
Medicina (B Aires); 2010; 70(5):457-62. PubMed ID: 20920967
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
Löwenberg M; Verhaar AP; van den Brink GR; Hommes DW
Trends Mol Med; 2007 Apr; 13(4):158-63. PubMed ID: 17293163
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory actions of glucocorticoids: molecular mechanisms.
Barnes PJ
Clin Sci (Lond); 1998 Jun; 94(6):557-72. PubMed ID: 9854452
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cells present an innate resistance to glucocorticoid treatment: implications for therapy of primary vasculitis.
Koenen P; Barczyk K; Wolf M; Roth J; Viemann D
Ann Rheum Dis; 2012 May; 71(5):729-36. PubMed ID: 22203687
[TBL] [Abstract][Full Text] [Related]
8. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
Newton R; Holden NS
Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
Löwenberg M; Stahn C; Hommes DW; Buttgereit F
Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between pro-inflammatory transcription factors and glucocorticoids.
Adcock IM; Caramori G
Immunol Cell Biol; 2001 Aug; 79(4):376-84. PubMed ID: 11488985
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways.
Ayroldi E; Cannarile L; Migliorati G; Nocentini G; Delfino DV; Riccardi C
FASEB J; 2012 Dec; 26(12):4805-20. PubMed ID: 22954589
[TBL] [Abstract][Full Text] [Related]
12. [Nongenomic effects of glucocorticoids].
Grzanka A; Jarzab J
Pneumonol Alergol Pol; 2009; 77(4):387-93. PubMed ID: 19722144
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of anti-inflammatory action of glucocorticoids.
Cato AC; Wade E
Bioessays; 1996 May; 18(5):371-8. PubMed ID: 8639160
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid activation of chromogranin A gene expression. Identification and characterization of a novel glucocorticoid response element.
Rozansky DJ; Wu H; Tang K; Parmer RJ; O'Connor DT
J Clin Invest; 1994 Dec; 94(6):2357-68. PubMed ID: 7989592
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic signaling pathways in rapid, nongenomic action of glucocorticoid.
Chen YZ; Qiu J
Mol Cell Biol Res Commun; 1999; 2(3):145-9. PubMed ID: 10662589
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms generating diversity in glucocorticoid receptor signaling.
Revollo JR; Cidlowski JA
Ann N Y Acad Sci; 2009 Oct; 1179():167-78. PubMed ID: 19906239
[TBL] [Abstract][Full Text] [Related]
17. Targeting inflammation using selective glucocorticoid receptor modulators.
De Bosscher K; Haegeman G; Elewaut D
Curr Opin Pharmacol; 2010 Aug; 10(4):497-504. PubMed ID: 20493772
[TBL] [Abstract][Full Text] [Related]
18. The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids.
Revest JM; Di Blasi F; Kitchener P; Rougé-Pont F; Desmedt A; Turiault M; Tronche F; Piazza PV
Nat Neurosci; 2005 May; 8(5):664-72. PubMed ID: 15834420
[TBL] [Abstract][Full Text] [Related]
19. [On genomic and nongenomic effects. Molecular basis of glucocorticoid action].
Eberhardt W; Kilz T
Pharm Unserer Zeit; 2003; 32(4):288-94. PubMed ID: 12899065
[No Abstract] [Full Text] [Related]
20. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
Schäcke H; Berger M; Rehwinkel H; Asadullah K
Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
